Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-080798
Filing Date
2024-07-18
Accepted
2024-07-18 14:56:19
Documents
1
Period of Report
2024-07-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2419673-2_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2419673-2_4seq1.xml 4 3125
  Complete submission text file 0001104659-24-080798.txt   4788
Mailing Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103
Business Address 1900 MARKET STREET SUITE 200 PHILADELPHIA PA 19103 6177728515
abrdn Life Sciences Investors (Issuer) CIK: 0000884121 (see all company filings)

EIN.: 043147016 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address C/O ABRDN 1900 MARKET STREET PHILADELPHIA PA 19103
Business Address
DiMartino Rose (Reporting) CIK: 0001998932 (see all company filings)

Type: 4 | Act: 34 | File No.: 811-06565 | Film No.: 241124574